Julien M. Buyck

Poitiers, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Optimizing antimicrobial susceptibility testing: cost and environmental benefits of MIC volume reduction.

Optimizing antimicrobial susceptibility testing: cost and environmental benefits of MIC volume reduction.

Journal: Antimicrobial agents and chemotherapy

Published: October 17, 2025

PKPD modeling of the inoculum effect of combined ceftazidime/avibactam and colistin against KPC-3 Klebsiella pneumoniae isolate.

PKPD modeling of the inoculum effect of combined ceftazidime/avibactam and colistin against KPC-3 Klebsiella pneumoniae isolate.

Journal: Antimicrobial agents and chemotherapy

Published: April 14, 2025

Diploid Genome Assembly of the Blastobotrys allociferrii Clinical Isolate CBS 18616.

Diploid Genome Assembly of the Blastobotrys allociferrii Clinical Isolate CBS 18616.

Journal: Mycopathologia

Published: February 20, 2025

Evaluation of in vitro pharmacodynamic drug interactions of ceftazidime-avibactam with tigecycline in ESBL- and carbapenemase producing Escherichia coli and Klebsiella pneumoniae.

Evaluation of in vitro pharmacodynamic drug interactions of ceftazidime-avibactam with tigecycline in ESBL- and carbapenemase producing Escherichia coli and Klebsiella pneumoniae.

Journal: International journal of antimicrobial agents

Published: October 09, 2024

Impact of mixed Staphylococcus aureus-Pseudomonas aeruginosa biofilm on susceptibility to antimicrobial treatments in a 3D in vitro model.

Impact of mixed Staphylococcus aureus-Pseudomonas aeruginosa biofilm on susceptibility to antimicrobial treatments in a 3D in vitro model.

Journal: Scientific reports

Published: August 17, 2024

Emergence of cefiderocol resistance during therapy in NDM-5-producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations.

Emergence of cefiderocol resistance during therapy in NDM-5-producing Klebsiella pneumoniae isolates harboring siderophore receptors mutations.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: July 17, 2024

(E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii.

(E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii.

Journal: International journal of pharmaceutics

Published: June 24, 2024

Assessment of inhaled cationic antibiotics in an in vitro model of Pseudomonas aeruginosa lung biofilm.

Assessment of inhaled cationic antibiotics in an in vitro model of Pseudomonas aeruginosa lung biofilm.

Journal: Microbial pathogenesis

Published: March 22, 2024

In vitro efficacy of combinations of antibiotics used in clinical practice on clinical isolates of Helicobacter pylori.

In vitro efficacy of combinations of antibiotics used in clinical practice on clinical isolates of Helicobacter pylori.

Journal: Helicobacter

Published: February 16, 2024

Pan-azole-resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11.

Pan-azole-resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11.

Journal: Mycoses

Published: November 16, 2023

Characterization of Pseudomonas aeruginosa resistance to ceftolozane-tazobactam due to ampC and/or ampD mutations observed during treatment using semi-mechanistic PKPD modeling.

Characterization of Pseudomonas aeruginosa resistance to ceftolozane-tazobactam due to ampC and/or ampD mutations observed during treatment using semi-mechanistic PKPD modeling.

Journal: Antimicrobial agents and chemotherapy

Published: September 11, 2023

An improved PKPD modeling approach to characterize the pharmacodynamic interaction over time between ceftazidime/avibactam and colistin from in vitro time-kill experiments against multidrug-resistant Klebsiella pneumoniae isolates.

An improved PKPD modeling approach to characterize the pharmacodynamic interaction over time between ceftazidime/avibactam and colistin from in vitro time-kill experiments against multidrug-resistant Klebsiella pneumoniae isolates.

Journal: Antimicrobial agents and chemotherapy

Published: September 08, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026